Acadia Pharmaceuticals Inc.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $385.0M | $282.2M | $177.7M | $258.0M | $253.6M | $217.7M | $319.6M | $155.1M |
| Accounts Receivable | $150.6M | $135.4M | $121.5M | $115.9M | $107.5M | $105.7M | $98.7M | $98.2M |
| Inventory | $108.7M | $112.3M | $111.4M | $106.0M | $110.5M | $103.0M | $91.7M | $86.7M |
| Total Current Assets | $1.22B | $1.10B | $1.06B | $1.08B | $960.6M | $870.9M | $938.3M | $788.3M |
| Property, Plant & Equipment | $17.1M | $14.7M | $7.5M | $3.7M | $3.5M | $3.5M | $4.2M | $4.0M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $103.4M | $106.2M | $108.9M | $111.6M | $114.3M | $117.1M | $119.8M | $105.5M |
| Total Assets | $1.74B | $1.61B | $1.56B | $1.33B | $1.23B | $1.13B | $1.19B | $976.9M |
| Liabilities | ||||||||
| Accounts Payable | $44.6M | $12.2M | $10.9M | $21.7M | $20.1M | $18.1M | $16.2M | $19.1M |
| Total Current Liabilities | $361.4M | $305.5M | $277.1M | $356.6M | $330.0M | $302.5M | $394.9M | $343.9M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $436.3M | $357.2M | $336.8M | $413.5M | $403.2M | $367.1M | $455.0M | $399.7M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-1.78B | $-1.81B | $-1.81B | $-2.09B | $-2.16B | $-2.19B | $-2.20B | $-2.35B |
| Total Stockholders' Equity | $1.31B | $1.25B | $1.23B | $917.3M | $822.4M | $765.2M | $732.8M | $577.2M |